Cargando…
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
The immunologic landscape of the host and tumor play key roles in determining how patients will benefit from immunotherapy, and a better understanding of these factors could help inform how well a tumor responds to treatment. Recent advances in immunotherapy and in our understanding of the immune sy...
Autores principales: | Nixon, Andrew B., Schalper, Kurt A., Jacobs, Ira, Potluri, Shobha, Wang, I-Ming, Fleener, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880594/ https://www.ncbi.nlm.nih.gov/pubmed/31775882 http://dx.doi.org/10.1186/s40425-019-0799-2 |
Ejemplares similares
-
PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer
por: Schalper, Kurt A
Publicado: (2014) -
Oncolytic virus immunotherapy: future prospects for oncology
por: Raja, Junaid, et al.
Publicado: (2018) -
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
por: Oh, Byeongsang, et al.
Publicado: (2021) -
Realizing the Potential for Recipient Immune Cells in Adoptive Immune Therapy
por: Qazi, Sanjive
Publicado: (2016) -
Is Vasospastic Coronary Disease More Common Than We Realize?
por: Minhas, Anum S., et al.
Publicado: (2022)